Model Validation and Selection in Metabolic Flux Analysis and Flux Balance Analysis

Joshua A.M. Kaste,Yair Shachar-Hill
2023-03-22
Abstract:13C-Metabolic Flux Analysis (13C-MFA) and Flux Balance Analysis (FBA) are widely used to investigate the operation of biochemical networks in both biological and biotechnological research. Both of these methods use metabolic reaction network models of metabolism operating at steady state, so that reaction rates (fluxes) and the levels of metabolic intermediates are constrained to be invariant. They provide estimated (MFA) or predicted (FBA) values of the fluxes through the network in vivo, which cannot be measured directly. A number of approaches have been taken to test the reliability of estimates and predictions from constraint-based methods and to decide on and/or discriminate between alternative model architectures. Despite advances in other areas of the statistical evaluation of metabolic models, validation and model selection methods have been underappreciated and underexplored. We review the history and state-of-the-art in constraint-based metabolic model validation and model selection. Applications and limitations of the X2-test of goodness-of-fit, the most widely used quantitative validation and selection approach in 13C-MFA, are discussed, and complementary and alternative forms of validation and selection are proposed. A combined model validation and selection framework for 13C-MFA incorporating metabolite pool size information that leverages new developments in the field is presented and advocated for. Finally, we discuss how the adoption of robust validation and selection procedures can enhance confidence in constraint-based modeling as a whole and ultimately facilitate more widespread use of FBA in biotechnology in particular.
Molecular Networks,Quantitative Methods
What problem does this paper attempt to address?
The paper aims to address the issues of model validation and selection in Metabolic Flux Analysis (MFA) and Flux Balance Analysis (FBA). Specifically, the paper focuses on the following aspects: 1. **Model Validation Methods**: - The paper reviews the history and current state of constraint-based metabolic model validation, discussing the widely used χ² goodness-of-fit test, its applications, and limitations. - It proposes supplementary and alternative validation methods, particularly for 13C-MFA (13C-Metabolic Flux Analysis). 2. **Model Selection Framework**: - The paper presents a comprehensive model validation and selection framework for 13C-MFA that incorporates information on metabolite pool sizes. - It emphasizes that adopting robust validation and selection procedures can enhance overall confidence in constraint-based modeling and promote the broader application of FBA in the biotechnology field. 3. **Specific Application Scenarios**: - The accuracy of FBA and 13C-MFA models is validated by comparing experimental measurements with model predictions. - It discusses how independent modeling and experimental techniques can further validate and correct metabolic flux estimation results. 4. **Existing Issues and Improvement Suggestions**: - It points out some issues with the χ² test in practical applications, such as difficulties in accurately estimating effective degrees of freedom and measurement error estimation inaccuracies. - It suggests retaining a portion of the data solely for final model validation during the model development process to avoid statistical bias. In summary, the paper aims to improve the reliability and accuracy of metabolic models by enhancing existing validation and selection methods, thereby better applying them in the fields of systems biology and biotechnology.